Heat Biologics, Inc.: Heat Biologics Completes Enrollment in Phase 2 Non-Small Cell Lung Cancer Trial
DURHAM, NC / ACCESSWIRE / July 9, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed to activate a patient’s immune system against cancer, today a…
FinanzNachrichten.de: Bestbewertete Nachrichten
